M3 Inc
TSE:2413

Watchlist Manager
M3 Inc Logo
M3 Inc
TSE:2413
Watchlist
Price: 2 229 JPY -3.19% Market Closed
Market Cap: 1.5T JPY

M3 Inc
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

M3 Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
M3 Inc
TSE:2413
Depreciation & Amortization
ÂĄ12.2B
CAGR 3-Years
23%
CAGR 5-Years
21%
CAGR 10-Years
33%
EM Systems Co Ltd
TSE:4820
Depreciation & Amortization
ÂĄ1.4B
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
7%
S
Software Service Inc
TSE:3733
Depreciation & Amortization
ÂĄ950.3m
CAGR 3-Years
59%
CAGR 5-Years
29%
CAGR 10-Years
11%
Medley Inc
TSE:4480
Depreciation & Amortization
ÂĄ1.7B
CAGR 3-Years
57%
CAGR 5-Years
77%
CAGR 10-Years
N/A
CareNet Inc
TSE:2150
Depreciation & Amortization
ÂĄ260.2m
CAGR 3-Years
40%
CAGR 5-Years
48%
CAGR 10-Years
24%
JMDC Inc
TSE:4483
Depreciation & Amortization
ÂĄ3B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
N/A
No Stocks Found

M3 Inc
Glance View

M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.

Intrinsic Value
1 966.91 JPY
Overvaluation 12%
Intrinsic Value
Price

See Also

What is M3 Inc's Depreciation & Amortization?
Depreciation & Amortization
12.2B JPY

Based on the financial report for Jun 30, 2025, M3 Inc's Depreciation & Amortization amounts to 12.2B JPY.

What is M3 Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
33%

Over the last year, the Depreciation & Amortization growth was 37%. The average annual Depreciation & Amortization growth rates for M3 Inc have been 23% over the past three years , 21% over the past five years , and 33% over the past ten years .

Back to Top